Holly John, Senior Director of Global Patient Advocacy and Medical Affairs at Agios Pharmaceuticals, shares insights from the company’s partnership with the sickle cell community on the RISE UP Phase 2/3 trial of mitapivat in sickle cell disease
Lead Editorial
